Table 3 Multivariate logistic regression analysis of risk factors associated with PICC-related venous thrombosis

Age > 65 years old

1.791

1.343–2.389

0.000

0.931

1.074

Male

1.398

1.057–1.849

0.019

0.732

1.367

White blood cell count > 9.5 × 109 /L

1.422

1.041–1.942

0.027

0.964

1.037

Hemoglobin concentration < 130 g/L

1.231

0.950–1.595

0.117

0.930

1.075

D-dimer concentration > 0.5 mg/L

1.198

0.882–1.628

0.247

0.955

1.047

APTT < 25 s

2.006

1.431–2.811

0.000

0.911

1.098

Lung Cancer

1.103

0.698–1.742

0.674

0.364

2.749

Gastrointestinal Tumor

2.191

1.406–3.414

0.001

0.922

1.084

Any infection

7.619

5.783–10.037

0.000

0.878

1.138

Smoking

1.045

0.715–1.528

0.818

0.675

1.481

Cisplatin

2.347

1.714–3.214

0.000

0.854

1.170

Carboplatin

1.192

0.779–1.824

0.419

0.431

2.322

Vincristine

2.329

1.447–3.749

0.000

0.941

1.063

Paclitaxel

1.223

0.915–1.635

0.175

0.759

1.318

5 Fr catheter

1.125

0.687–1.802

0.665

0.832

1.202

Polyurethane PICC

2.449

1.863–3.219

0.000

0.693

1.442

Open-ended catheter

1.660

1.131–2.439

0.010

0.842

1.187

Keeping time of the catheter (days)

1.003

1.001–1.005

0.005

0.986

1.014

Risk factors for peripherally inserted central catheter-related venous thrombosis in adult patients with cancer

Risk factors for peripherally inserted central catheter-related venous thrombosis in adult patients with cancer

Risk factors for peripherally inserted central catheter-related venous thrombosis in adult patients with cancer

Risk factors for peripherally inserted central catheter-related venous thrombosis in adult patients with cancer

Risk factors for peripherally inserted central catheter-related venous thrombosis in adult patients with cancer